Haziq Kamaruddin: 27-year-old Malaysian Olympic Archer Develops Blood Clots, Dead 10 Days After Second Pfizer mRNA Shot
By The COVID Blog
Mr. Haziq Kamaruddin
KAJANG, SELANGOR — A 27-year-old competitive archer was training for a chance to represent Malaysia in the 2021 Tokyo Summer Olympics. He is now dead, and Malaysian officials are calling it a coincidence.
Mr. Haziq Kamaruddin received the first dose of experimental Pfizer mRNA on April 13, the second day of Ramadan in the country. He received the second dose on May 4. He shared photos of the first dose on Instagram.
The sign translates roughly to “I’ve been vaccinated.” All Malaysian athletes who wished to compete internationally were forced to take the shots on these same dates.
Mr. Kamaruddin apparently suffered no immediate side effects. Hari Raya Aidilfitri (Eid al-Fitr) commenced on May 12. It is a two-day Muslim religious holiday marking the end of Ramadan. A family member told the Malay Mail that Mr. Kamaruddin performed Fajr (Subuh), the first Muslim prayer of the day, on Friday morning, May 14 after Hari Raya Aidilfitri ended. He went to the bathroom after the prayer, came out, and suddenly collapsed. Mr. Kamaruddin died less than two hours later at his home.
6 Responses
I am really impressed with your writing skills and also with the layout on your
weblog. Is this a paid theme or did you modify it yourself?
Anyway keep up the excellent quality writing, it’s rare to see
a great blog like this one today.
Hello to all, as I am actually keen of reading this webpage’s post to be updated on a regular basis.
It includes fastidious stuff.
I always emailed this weblog post page to all
my associates, since if like to read it afterward my
links will too.
bookmarked!!, I like your web site!
Hey! Would you mind if I share your blog with my myspace group?
There’s a lot of people that I think would really
appreciate your content. Please let me know. Cheers
If some one needs to be updated with newest technologies afterward he must be go to see this web
site and be up to date every day.